MR to Evaluate Deregulation in Human Disease and Damage.

Professor Carolyn Mountford MSc(Oxon) DPhil(Oxon) MS(Harv) is CEO and Director of Research for Australia’s Translational Research Institute. Carolyn has been the Professor of Radiology at Harvard Medical School since 2007, and until recently, the Director of the Centre for Clinical Spectroscopy at the Brigham and Women’s Hospital in Boston. Professor Mountford and her team have been a worldwide development site for Siemens since 1999. She is a co-inventor of the diagnostic protocol to monitor women at high risk for breast cancer identifying metabolic deregulations in their breast tissue that precede tumour growth. The same technology is shown to identify changes to the brain associated with learning, memory, Post-Traumatic Stress Disorder (PTSD) and injury from blast and impact. Her team is under contract to the USA and Australian military to develop this approach to improve the health of soldiers.